If you grew up with hemophilia, or you’re a parent of a child who was just diagnosed, you know that the rhythm of life is built around something invisible. A bumped knee that any other kid would shake off can mean a long evening of ice, elevation, and a factor infusion. A planned weekend trip means packing a small clinic in a cooler. The disease never leaves the room.
The good news is that home factor therapy has transformed what’s possible. Most hemophilia patients today never set foot in a hospital for routine treatment. Factor is delivered to your door. You (or your caregiver, or your child, once they’re old enough) infuse it at home, on your schedule. The hospital is for emergencies, not weekly appointments.
This guide walks through how home factor therapy actually works in 2026: prophylaxis vs on-demand, the difference between standard and extended half-life products, where Hemlibra fits in, how to handle a bleed, how to store and travel with factor, and how to teach a child to do their own infusions when the time comes. We’ll also be honest about the parts that are still hard.
| Need a specialty pharmacy that knows hemophilia inside and out? We coordinate factor delivery, training, and 24/7 clinical support for patients and families. Many of our hemophilia patients have been with us since childhood. ▶ Call (949) 555-0100 · Talk to Our Hemophilia Team |
Hemophilia Basics: Quick Refresher
Hemophilia is a genetic bleeding disorder caused by missing or low levels of a clotting protein. The two main types:
- Hemophilia A — deficiency of clotting factor VIII (FVIII). Accounts for roughly 80% of cases.
- Hemophilia B — deficiency of clotting factor IX (FIX). Sometimes called Christmas disease.
Severity is classified by baseline factor activity level:
- Severe — less than 1% factor activity. Spontaneous bleeds, especially in joints. Requires regular treatment.
- Moderate — 1-5% factor activity. Bleeds with minor trauma; rare spontaneous bleeds.
- Mild — 5-40% factor activity. Bleeds with significant injury or surgery.
The treatment landscape has changed dramatically over the last decade. There are now multiple recombinant (lab-made, no human plasma), extended half-life (lasting longer between doses), and even non-factor therapies (like Hemlibra) that have made hemophilia a far more manageable condition than it was even ten years ago.
Prophylaxis vs On-Demand: The Two Treatment Approaches
Hemophilia treatment falls into two general approaches, and which one you use depends on your severity, lifestyle, and treatment history.
Prophylaxis (preventive treatment)
Regular factor or non-factor doses (typically 1-3 times per week, or every 2 weeks for some extended half-life products) to keep your factor levels high enough to prevent bleeds before they happen. Prophylaxis is the standard of care for severe hemophilia and is increasingly used for moderate hemophilia. It dramatically reduces joint damage over a lifetime.
On-demand (episodic treatment)
Factor is given only when a bleed occurs. Used for milder hemophilia, or for severe patients between prophylactic doses if a breakthrough bleed happens. On-demand alone (without prophylaxis) is now uncommon for severe disease — long-term joint damage is the main reason.
| 💡 Why prophylaxis matters Recurrent joint bleeds cause cumulative damage called hemophilic arthropathy. By the time someone with severe hemophilia reaches their 30s on on-demand-only treatment, joint damage is often substantial. Prophylaxis prevents this. The difference in lifelong joint health between prophylaxis-from-childhood and on-demand-only is enormous. |
The Treatment Options Available Today
Standard half-life factor concentrates
These were the standard for years. Recombinant FVIII or FIX, infused 2-3 times per week (FVIII) or 2 times per week (FIX) for prophylaxis. Examples include Advate, Kovaltry, BeneFIX, and Ixinity.
Extended half-life (EHL) factor concentrates
Engineered to stay in the bloodstream longer, allowing less frequent dosing. Most patients on EHL products dose every 3-5 days for FVIII (Eloctate, Adynovate, Esperoct, Jivi) or every 7-14 days for FIX (Alprolix, Idelvion, Rebinyn). For families, this often means dropping from 3 weekly infusions to 1-2.
Hemlibra (emicizumab) — the non-factor option for hemophilia A
Hemlibra is a subcutaneous (under-the-skin) injection given weekly, every 2 weeks, or every 4 weeks. It’s a bispecific antibody that mimics the function of factor VIII without actually being factor VIII. It’s revolutionary for many patients, especially those with inhibitors or those who struggle with venous access.
Hemlibra is not a replacement for breakthrough bleed treatment — patients still need access to factor (or another agent) for active bleeds. But for daily prophylactic protection, weekly or monthly Hemlibra has changed lives, particularly for kids who can avoid the IV access challenge.
| Approach | Frequency | Route | Best For |
|---|---|---|---|
| Standard FVIII | 2-3x/week | IV | Cost-conscious, comfortable with frequent IV |
| Extended HL FVIII | Every 3-5 days | IV | Reduced infusion burden, prophylaxis |
| Hemlibra | Weekly to monthly | Subcutaneous | Difficult IV access, inhibitors, kids |
| Standard FIX | 2x/week | IV | Hemophilia B, lower cost |
| Extended HL FIX | Every 7-14 days | IV | Hemophilia B, fewer infusions |
| Switching factor products or considering Hemlibra? Our team coordinates the transition, runs benefits, and ensures you have continuous coverage. Most switches are seamless when planned ahead. ▶ Schedule a Consult · (949) 555-0100 |
Teaching a Child to Self-Infuse
This is the part of the journey that families think about for years before it happens. The traditional milestone in hemophilia care is the child learning to do their own infusions, usually somewhere between ages 8 and 14, though it varies widely by child, by veins, and by family.
Here’s how the progression typically works:
- Early childhood (ages 0-5). Parents do all infusions. Many young children have a port-a-cath placed to make IV access easier. Others use peripheral veins from the start.
- Middle childhood (ages 5-9). The child watches, helps with parts of the process (mixing factor, placing the bandage), and starts understanding why infusions matter. Some kids start helping with the needle stick at this age.
- Late childhood (ages 9-12). Many children learn to insert their own needle and run their own infusion under parental supervision. This often coincides with a desire for more independence.
- Adolescence (ages 12+). Most kids who started learning early are independent self-infusers by their teens. They handle their own factor when traveling, at sleepovers, and (eventually) at college.
| ♥ A note for parents Every child is different. Some kids learn at 8 and want to do everything themselves. Others reach 16 and still prefer their mom or dad to do the infusion. Both are okay. The goal is comfort with the medication, not a forced timeline. Hemophilia treatment centers and specialty pharmacies offer pediatric self-infusion classes to make this transition feel less daunting for the whole family. |
Storage and Travel: The Logistics
Storage at home
- Most factor concentrates are stored in the refrigerator at 36-46°F (2-8°C).
- Many products are stable at room temperature for a defined period (commonly 3-6 months) so you have flexibility.
- Hemlibra is refrigerated but stable at room temperature for up to 7 days.
- Always check the package insert for your specific product — storage rules vary.
- Keep your factor away from extreme heat, direct sunlight, and freezing temperatures (freezing damages the protein).
Traveling with factor
- Factor and Hemlibra can be carried in a small medical-grade cooler with ice packs (not in direct contact with the vials).
- Always carry factor in your carry-on bag, never checked luggage. Cargo holds can freeze.
- TSA accepts factor and infusion supplies as medical equipment. Bring a letter from your prescriber if you want to skip extra screening conversations.
- For international travel, bring extra factor (your specialty pharmacy can help calculate quantity), a translated prescriber letter, and the manufacturer’s contact information for emergencies.
- For long road trips, plan refrigeration access at hotels or use travel coolers rated for extended cold maintenance.
| ⚠️ If your factor is exposed to a temperature excursion Don’t use it without checking. Call your specialty pharmacy. We can usually verify with the manufacturer whether the product is still safe based on the actual exposure (e.g., 3 hours at 75°F is different from 12 hours in a hot car). Replacement product can typically be expedited if needed. |
What to Do During a Bleeding Episode
This is the part every patient and family memorizes. The basic principles are universal, regardless of which factor product you use:
- Treat early. The single most important rule. The earlier factor is given after a bleed starts, the less damage is done and the less factor is needed overall. “When in doubt, treat” is the standard guidance for severe hemophilia.
- Identify the type of bleed. Joint bleeds (knees, ankles, elbows are most common) feel like tightness, warmth, and tingling before becoming swollen and painful. Muscle bleeds present as tightness or hardness. Head injuries always require urgent treatment and medical evaluation, regardless of severity.
- Apply R.I.C.E. Rest, Ice, Compression, Elevation — the same principles as any other injury, applied alongside factor.
- Dose appropriately. Your hemophilia treatment center will provide a treatment plan with specific factor doses for joint bleeds, muscle bleeds, and major bleeds. Keep a copy on the fridge and in your phone.
- Document everything. Date, time, location of bleed, dose given, response. Apps like MyCBDR or paper logs both work. Your treatment center reviews these to adjust your prophylaxis plan.
- Call for help when needed. Head trauma, abdominal pain, throat or neck bleeding, vision changes, or any bleed you can’t control with home treatment is an emergency. Call your hemophilia treatment center or go to the ER immediately, factor in hand if possible.
How a Specialty Pharmacy Supports Hemophilia Families
Hemophilia is one of the longest-tenure relationships in specialty pharmacy. Many of our hemophilia patients started with us as children and are now adults; many parents who infuse for their kids in elementary school are still with us when those kids are in college. Continuity matters when your therapy is lifelong.
What we coordinate:
- Reliable factor delivery on your schedule, with built-in inventory monitoring so you never run low
- Cold-chain shipping with temperature monitoring, so you know your product arrived safely
- Coordination with your hemophilia treatment center on dose changes, lab work, and inhibitor surveillance
- Pediatric self-infusion training resources and connections to nurse educators
- 24/7 pharmacist availability for bleed questions, dosing questions, and travel coordination
- Insurance and prior authorization renewals (often required annually)
- Co-pay assistance and foundation grant identification (HFA, NHF, Hemophilia Federation, Patient Services Inc.)
- Travel supply planning, including international shipments where possible
We’re not a substitute for your hemophilia treatment center. We’re the operational layer that keeps the medication, the supplies, and the logistics flowing smoothly so your HTC can focus on your clinical care and your family can focus on, well, being a family.
| Looking for a specialty pharmacy your family can stay with? We treat hemophilia patients as long-term partners, not transactions. Talk to a pharmacist who knows the disease and the families who live with it. ▶ Contact River’s Edge · (949) 555-0100 |
Frequently Asked Questions
Q: What’s the difference between Hemlibra and factor?
Factor concentrates (FVIII or FIX) are direct replacements for the missing clotting protein. They’re given IV. Hemlibra is a different molecule that mimics factor VIII’s function — it’s not factor itself, but it works in its place for daily protection in hemophilia A. Hemlibra is given subcutaneously (under the skin), much less frequently. Many hemophilia A patients on Hemlibra still keep factor on hand for breakthrough bleed treatment.
Q: Is Hemlibra appropriate for everyone with hemophilia?
Hemlibra is FDA-approved for hemophilia A only (not hemophilia B), with or without inhibitors. It’s not appropriate for everyone. Patients with active inhibitors require special considerations during transitions. Your hematologist will discuss whether Hemlibra fits your specific situation.
Q: What is an inhibitor and what happens if I develop one?
An inhibitor is an antibody your immune system creates against factor, making factor less effective. About 25-30% of people with severe hemophilia A develop an inhibitor at some point, often within the first 50 exposure days. If you develop one, your hematologist will adjust your treatment plan, which may include immune tolerance induction (ITI) therapy, bypassing agents (FEIBA, NovoSeven), or a switch to Hemlibra. Inhibitors are challenging but manageable with the right team.
Q: How is factor shipped?
Factor is shipped overnight in temperature-controlled packaging with cold packs. We coordinate delivery to your preferred address (home, vacation rental, family member’s house) and require an adult signature on receipt. Temperature loggers are included on most shipments so any in-transit excursion is detected before you use the product.
Q: Will my insurance cover home factor therapy?
Almost always. Hemophilia care is recognized by virtually all commercial insurance, Medicaid, and Medicare as requiring specialty pharmacy management. Your specialty pharmacy will run benefits and identify any out-of-pocket costs before shipping. Manufacturer co-pay assistance and disease-specific foundation grants make hemophilia therapy affordable for nearly all insured patients.
Q: How young can a child start home factor infusions?
Many children with severe hemophilia start prophylaxis between ages 1 and 2. Parents handle the infusions during early childhood, often with the help of a port-a-cath. Children typically begin learning to participate in the process by age 6-8 and many start self-infusing peripheral veins between 9-12, depending on the child.
Q: What if I run out of factor or Hemlibra unexpectedly?
Call us immediately. We can typically expedite a replacement shipment within 24 hours, and in true emergencies we can coordinate same-day pickup at a partnering location or emergency dispense through your hemophilia treatment center. Inventory tracking is part of our service so this rarely happens, but when it does, we move fast.
| 💡 Schema markup note for developers FAQPage schema for the 7 Q&As. Drug schema entries for major factor products (Advate, Adynovate, Eloctate, Esperoct, Jivi, Kovaltry, Hemlibra, Alprolix, Idelvion, Rebinyn). MedicalCondition schema for hemophilia A and hemophilia B with codeValue from ICD-10. HowTo schema for the bleeding episode action steps. |
The Takeaway
Home factor therapy gives families control over hemophilia in a way that wasn’t possible a generation ago. With prophylactic dosing, extended half-life products, and Hemlibra, most patients today live full, active lives with hemophilia as a manageable background condition rather than a daily limitation.
The medication is one piece. The other pieces — reliable delivery, training, lab coordination, bleed support, insurance navigation, and 24/7 access to pharmacists who understand the disease — are what make home therapy actually work for years on end. Those pieces are what a specialty pharmacy is for. Choose one that knows hemophilia, and you’ll feel the difference for the next decade.